---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-003280"
form_type: "8-K"
ticker: "EYPT"
cik: "0001314102"
company_name: "EyePoint, Inc."
filed_at: "2025-01-08T23:59:59+00:00"
generated_at: "2026-05-28T06:20:27.746486+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# EyePoint appoints Dr. Reginald Sanders, retina specialist and former ASRS president, to board

## Summary
- Board expanded to nine members; Dr. Sanders appointed effective Jan 8, 2025.
- Receives $45,000 annual cash retainer and option for 80,000 shares vesting over 3 years.
- Sanders brings expertise as ex-president of American Society of Retina Specialists and PI for Lucentis.
- He served as president and managing partner of Retina Group of Washington, largest U.S. retina practice.
- Appointment coincides with Phase 3 trials for wet AMD and positive interim Phase 2 DME data.

## SEC filing metadata
- accession: 0000950170-25-003280
- form_type: 8-K
- ticker: EYPT
- cik: 0001314102
- company_name: EyePoint, Inc.
- filed_at: 2025-01-08T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1314102/000095017025003280/0000950170-25-003280-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1314102/000095017025003280/eypt-20250108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-003280
- JSON: https://secwatch.observer/filing/0000950170-25-003280.json
- Plain text: https://secwatch.observer/filing/0000950170-25-003280.txt

## Key facts
- Executive change
  Dr. Reginald Sanders was appointed as Director at EyePoint, Inc..
  - Action: appointed
  - Role: Director
  source text: appointed Dr. Reginald Sanders, M.D. to fill the vacancy on the Board, effective January 8, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1314102/000095017025003280/0000950170-25-003280-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.